Currently predicting for Thu, 4 Jun 2026

HROW Prediction Chart

HROW Predictions History

Latest community submissions for HROW.
Predictor Target Session Target Price Result Direction Accuracy Score
Ti Li Ti Li @TiLi.161916
Jul 20, 2021 $7.50 +2.74% $7.30 X 97.26% 1
May 6, 2019 $4.66 -0.85% $4.70 X 99.15% 2
Apr 29, 2019 $4.82 -0.62% $4.85 X 99.38% 3
StockVader StockVader Merchant
Feb 15, 2019 $6.19 +0.49% $6.16 X 99.50% 4
Feb 15, 2019 $6.20 +0.65% $6.16 X 99.40% 3
JS JS Pro
Jan 8, 2019 $5.55 -9.02% $6.10 X 91.00% 0
SAM SAM
Jan 8, 2019 $5.53 -9.34% $6.10 X 90.70% 0
JS JS Pro
Oct 29, 2018 $4.00 -0.99% $4.04 X 99.00% 1
Oct 29, 2018 $2.08 -48.51% $4.04 X 51.50% 0
Apr 6, 2017 $1.92 -49.74% $3.82 X 50.30% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for HROW with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT IMPRIMIS PHARMACEUTICALS
Imprimis Pharmaceuticals
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharma...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE